NSHS — Nanosphere Health Sciences Balance Sheet
0.000.00%
Last trade - 00:00
- CA$0.21m
- CA$0.19m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.212 | 0.033 | 0.013 | 0.131 | 0.055 |
Net Total Receivables | 0.026 | 0.047 | 0.003 | 0.002 | 0.005 |
Prepaid Expenses | |||||
Total Current Assets | 0.313 | 0.14 | 0.016 | 0.133 | 0.06 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.266 | 0.045 | 0 | — | — |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Total Assets | 1.32 | 0.334 | 0.055 | 0.133 | 0.06 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.481 | 1.21 | 1.51 | 1.21 | 1.37 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.481 | 1.25 | 1.51 | 1.21 | 1.37 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.838 | -0.919 | -1.45 | -1.08 | -1.31 |
Total Liabilities & Shareholders' Equity | 1.32 | 0.334 | 0.055 | 0.133 | 0.06 |
Total Common Shares Outstanding |